- Home
- SBET vs MNKD Comparison
SBET vs MNKD Comparison
Compare SBET & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBET | MNKD |
|---|---|---|
| Founded | 1995 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2025 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SBET | MNKD |
|---|---|---|
| Price | $5.39 | $4.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $18.71 | $8.69 |
| AVG Volume (30 Days) | ★ 11.2M | 5.2M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $28,055,000.00 | ★ $348,966,000.00 |
| Revenue This Year | $105.19 | $35.81 |
| Revenue Next Year | $13.53 | $11.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 666.04 | 22.23 |
| 52 Week Low | $4.46 | $2.23 |
| 52 Week High | $40.46 | $6.51 |
Technical Indicators
Market Signals| Indicator | SBET | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 53.43 |
| Support Level | $5.06 | $3.77 |
| Resistance Level | $5.72 | $4.29 |
| Average True Range (ATR) | 0.32 | 0.23 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 75.40 | 35.26 |
Price Performance
Historical ComparisonAbout SBET SharpLink Gaming Ltd.
SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.